Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Email

Michelle Ho, Ph.D., joined the Laboratory of Translational Genomics (LTG) in 2020 as a postdoctoral fellow in the laboratory of Ludmila Prokunina-Olsson, Ph.D., LTG Director and senior investigator. Dr. Ho earned her Ph.D. in biological sciences in 2020 from the City of Hope Irell & Manella Graduate School in Duarte, California. Her previous research focused on the development of gene editing tools for various inherited disorders. Working with Drs. John Burnett and John Rossi, her doctoral research focused on developing methods to import CRISPR/Cas systems into mitochondria and optimizing CRISPR designs to target mutations in mitochondrial DNA.

Dr. Ho's research focuses on using CRISPR-based methods to screen genetic risk variants and functionally characterize their relationships to bladder cancer development, under the mentorship of Dr. Prokunina-Olsson.

Email